Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Patient-derived xenografts mirror the proteomic profile of human glioblastoma: implications for personalized drug development.

Publication ,  Journal Article
Kwatra, MM; Brown, KE; Chagoya, G; Keir, ST; Bigner, DD; Sampson, JH
Published in: Neuro Oncol
July 2014

(blind field).

Duke Scholars

Published In

Neuro Oncol

DOI

EISSN

1523-5866

Publication Date

July 2014

Volume

16 Suppl 3

Start / End Page

iii38

Location

England

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kwatra, M. M., Brown, K. E., Chagoya, G., Keir, S. T., Bigner, D. D., & Sampson, J. H. (2014). Patient-derived xenografts mirror the proteomic profile of human glioblastoma: implications for personalized drug development. Neuro Oncol, 16 Suppl 3, iii38. https://doi.org/10.1093/neuonc/nou208.57
Kwatra, M. M., K. E. Brown, G. Chagoya, S. T. Keir, D. D. Bigner, and J. H. Sampson. “Patient-derived xenografts mirror the proteomic profile of human glioblastoma: implications for personalized drug development.Neuro Oncol 16 Suppl 3 (July 2014): iii38. https://doi.org/10.1093/neuonc/nou208.57.
Kwatra MM, Brown KE, Chagoya G, Keir ST, Bigner DD, Sampson JH. Patient-derived xenografts mirror the proteomic profile of human glioblastoma: implications for personalized drug development. Neuro Oncol. 2014 Jul;16 Suppl 3:iii38.
Kwatra, M. M., et al. “Patient-derived xenografts mirror the proteomic profile of human glioblastoma: implications for personalized drug development.Neuro Oncol, vol. 16 Suppl 3, July 2014, p. iii38. Pubmed, doi:10.1093/neuonc/nou208.57.
Kwatra MM, Brown KE, Chagoya G, Keir ST, Bigner DD, Sampson JH. Patient-derived xenografts mirror the proteomic profile of human glioblastoma: implications for personalized drug development. Neuro Oncol. 2014 Jul;16 Suppl 3:iii38.
Journal cover image

Published In

Neuro Oncol

DOI

EISSN

1523-5866

Publication Date

July 2014

Volume

16 Suppl 3

Start / End Page

iii38

Location

England

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences